Human IgG1 (M252Y, S254T, T256E) Kappa Isotype Control (mAb, carrier free)

Cat. No. / Size
Price
Availability
Qty
DNP-C12P1-100ug
$165.00
In Stock - Delivery in 1-2 business days
DNP-C12P1-1mg (500ug X 2)
$720.00
In Stock - Delivery in 1-2 business days
DNP-C12P1-25mg
Inquire
DNP-C12P1-100mg
Inquire
DNP-C12P1
Sub-Total :
$ 0
Customize Product Request Quote
Contact Us
Contact Us
Sub-Total:
$ 0
  • Product Details
  • Performance Data
  • Reviews & Citations
  • Important Statement
  • Resources
Source

Chimeric Human IgG1 (M252Y, S254T, T256E) Kappa Isotype Control (mAb) is recombinantly expressed in HEK293. It consists of mouse variable regions genetically fused to human IgG1 (M252Y, S254T, T256E) constant domains.

Antibody Type

Recombinant Monoclonal

Clone

C1692

Isotype

Human IgG1 (M252Y, S254T, T256E), Kappa

Host Species

Mouse

Specificity

This product is a specific antibody specifically reacts with DNP.

Application
Application
Recommended Use / Performance
ELISA
0.2-2 μg/mL
Purification

Protein A purified.

Aggregation

Less than 10%, as determined by SEC-MALS.

Concentration

Please refer to the Certificate of Analysis (CoA).

Form

Lyophilized

Formulation

Lyophilized from a 0.22 μm-filtered solution in PBS (pH 7.4), with trehalose as protectant.

Please contact us for customized product forms or formulations.

25 mg or larger size will be supplied as liquid and shipped by dry ice. Please inquire the dry ice shipping cost.

Reconstitution

Please refer to the Certificate of Analysis (CoA) for specific instructions.

Shipping

Lyophilized product is shipped at ambient temperature.

Storage

For long term storage, the product should be stored in a lyophilized state at -20°C or lower.

Please avoid repeated freeze-thaw cycles.

This product is stable after storage at:
  • -20°C to -70°C for 12 months in lyophilized state;
  • -70°C for 3 months under sterile conditions after reconstitution.
Notices

Product Specific Notices: For research use only.

Background

Fc engineered isotype controls are designed to evaluate effector functions such as FcγR binding, FcRn interaction, ADCC, and CDC. Each variant is functionally validated, providing a reliable negative control framework for antibody mechanism studies and therapeutic development.